Are we ‘playing God’ if we screen IVF embryos for IQ potential?

Image credit: ERproductions Ltd

IVF clinics may soon use a controversial screening technique to get rid of embryos which are likely to grow up with low IQs. A company in the US offering tests which can pick out ‘mental disabilities’ – and, in theory, predict intelligence – has confirmed it is in talks with fertility clinics.

The news has stoked fears about a rise in designer babies, which could be created by parents wanting to erase undesirable traits from their children. Experts say it is ‘repugnant’ to think about terminating embryos because they are expected to have lower than average intelligence.

Genomic Prediction, based in New Jersey, can now offer tests to calculate the risk of complex conditions like heart disease.

Related article:  'First ever' human CRISPR trial targets rare beta thalassemia blood disorder

While the company says it will only test embryos to find those at a high risk of serious medical conditions – like breast cancer, diabetes and inflammatory bowel disease – it expects people to one day want IQ predictions.

‘I think people are going to demand that,’ said Genomic Prediction’s co-founder, Stephen Hsu. ‘If we don’t do it, some other company will.’

Genomic Prediction’s new test raises huge ethical dilemmas and concerns about ‘playing God’, which have been simmering for years.

Read full, original post: Designer baby fears grow as experts slam ‘repugnant’ new test that can predict an IVF embryos’ risk of having a low IQ

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend